Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Aggrenox 25mg/200mg Capsule MR: Preventing Blood Clots and Strokes
Introduction:
Aggrenox 25mg/200mg Capsule MR is a combination of two medications primarily aimed at preventing clot formation in the blood vessels. It also helps prevent recurrent stroke in patients with a history of prior stroke or transient ischemic attack (mini-stroke).
Key Information:
Type of Medication: Combination antiplatelet therapy
Active Ingredients: Aspirin and Dipyridamole
Administration: Should be taken with food regularly at the same time each day
Uses of Aggrenox 25mg/200mg Capsule:
Prevention of Blood Clots: Aggrenox 25mg/200mg Capsule MR is utilized to prevent the formation of blood clots, particularly in individuals at risk of stroke or other clot-related conditions.
Benefits of Aggrenox 25mg/200mg Capsule:
In Prevention of Blood Clots:
Antiplatelet Action: Aggrenox 25mg/200mg Capsule MR inhibits platelet aggregation, preventing the formation of blood clots within the blood vessels and arteries.
Reduced Risk of Cardiovascular Events: By maintaining blood flow and preventing clot formation, this medication helps reduce the risk of heart attack, stroke, deep vein thrombosis, and pulmonary embolism.
Prevention of Stroke Recurrence: In patients with a history of prior stroke or transient ischemic attack (TIA), Aggrenox reduces the likelihood of recurrent stroke, thereby improving long-term outcomes and reducing disability.
Combination Therapy: The combination of Aspirin and Dipyridamole in Aggrenox provides dual antiplatelet effects, enhancing its efficacy in preventing clot formation and stroke recurrence.
Mechanism of Action of Aggrenox 25mg/200mg Capsule:
Dual Antiplatelet Therapy: Aggrenox 25mg/200mg Capsule MR combines the actions of two antiplatelet medications, Aspirin and Dipyridamole. Aspirin inhibits platelet aggregation by blocking the formation of thromboxane A2, a potent platelet aggregator. Dipyridamole acts synergistically with Aspirin to further inhibit platelet function, thereby reducing the risk of stroke and other thrombotic events.
Beside this well also export in other countries